RT Journal Article
SR Electronic
T1 Blinatumomab as postremission therapy replaces consolidation and substantial parts of maintenance chemotherapy and results in stable MRD negativity in children with newly diagnosed B-lineage ALL
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e008213
DO 10.1136/jitc-2023-008213
VO 12
IS 6
A1 Mikhailova, Ekaterina
A1 Popov, Alexander
A1 Roumiantseva, Julia
A1 Budanov, Oleg
A1 Lagoyko, Svetlana
A1 Zharikova, Liudmila
A1 Miakova, Natalia
A1 Litvinov, Dmitry
A1 Khachatryan, Lili
A1 Pshonkin, Alexey
A1 Ponomareva, Natalia
A1 Boichenko, Elmira
A1 Varfolomeeva, Svetlana
A1 Dinikina, Julia
A1 Novichkova, Galina
A1 Henze, Guenter
A1 Karachunskiy, Alexander
YR 2024
UL http://jitc.bmj.com/content/12/6/e008213.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.